TABLE 5.
Summary of HBsAg detection by NEXT in the 4 patient cohorts
| Patient cohort | No. of samples tested | Incremental detection by NEXT |
|
|---|---|---|---|
| No. | % | ||
| Group 1, HBsAg-negative, NAT-yield blood donors | 200 | 10 | 5 |
| Group 2, HBsAg-negative patients with HBV reactivationa | 20 | 1 | 5 |
| Group 3, patients with spontaneous HBsAg seroclearance | 800 | 59 | 7.3 |
| Group 4, HBsAg-negative individuals from a community project | 100 | 7 | 7 |
a
The 18 HBsAg-negative patients who did not have HBV reactivation upon receiving immunosuppressive therapy were not included in this table.